Global Pneumonia Therapeutics Market 2017 to 2021 Report Available at

77 adds “Global Pneumonia Therapeutics Market 2017-2021” new reports to its research database. The report spread across 87 pages with tables and figures in it.


The analysts forecast the global pneumonia therapeutics market to grow at a CAGR of 6.66% during the period 2017-2021. Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. Pneumonia therapeutics market encompasses drugs and vaccines used for the treatment of pneumonia along with oxygen therapy. The global pneumonia therapeutics market is an important part of the global respiratory disorder drugs market. The treatment of pneumonia involves three major categories, namely, vaccines, drugs, and oxygen therapy. Oxygen therapy is often used as a supplement to other therapies when the patient faces difficulty in breathing.
Get more details about report at .


Researcher recognizes the following companies as the key players in the global pneumonia therapeutics market: GlaxoSmithKline, Merck Sharp & Dohme, Novartis, and Pfizer.

Other Prominent Vendors in the market are: AstraZeneca, Bayer, Biotest, Ono Pharmaceutical, and Tetraphase Pharmaceuticals.

Commenting on the report, an analyst team said: “The latest trend gaining momentum in the market is Strong pipeline.The pipeline molecules in the respiratory disorder drugs market are rising at a good pace as consistent funding opportunity for R&D are available, and it is expected to fuel the market growth during the forecast period. For example, one of the popular funding bodies, Bill & Melinda Gates Foundation is supporting a new vaccine development by providing financial aid to combat pneumococcal disease in neonates.”
Order a Purchase Report Copy at .
According to the report, one of the major drivers for this market is Increased awareness about prophylaxis by vaccines. The awareness about prophylaxis has increased significantly in the past few years, and as a result, the world population is preferring to opt for preventive measures to reduce the possibility of disease onset. Preference to prevent pneumonia works as growth booster for the pneumonia vaccine market. Federal bodies also contribute significantly to awareness-raising campaigns. For instance, the National Institutes of Health (NIH) recommends regular pneumococcal vaccinations in its clinical guidelines for geriatric patients and patients at high risk for pneumonia. Such recommendations help population become aware of prophylaxis treatments thereby, driving the growth of the pneumonia therapeutics market.

Further, the report states that one of the major factors hindering the growth of this market is New strains of MDR bacteria. The global pneumonia therapeutics market includes antimicrobials as one of the key therapeutic regimens for the treatment of pneumonia. The rising bacterial resistance is a challenge because the available treatment options are losing their effectiveness. Usually, antimicrobials are prescribed for multiple diseases, which results in repetitive exposure of the microbe to the drug. This unnecessary exposure to antimicrobials can contribute to multi-drug resistance in bacteria. As per the CDC, antibiotics are not prescribed optimally in 50% of the cases, which implies that they are prescribed in the scenarios when they are not required. Incorrect dosing and duration of antibiotics also result in drug resistance. Transmission of resistant bacterial strains from one person to other and from non-human sources are also contributing to the development of new MDR bacterial strains.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Inquire before buying at .


About Us:                  is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.


Contact Us

Mr. Jeet Jain

Sales Manager

+1-240-284-8070 / +44-20-3290-4151

Connect with us:  Google+ | LinkedIn | Twitter | Facebook